INVITATION
SYMPOSIUM:
BRAIN DISEASES
– WHY TO INVEST IN
RESEARCH IN FINLAND
WELCOME
SYMPOSIUM:
BRAIN DISEASES
– WHY TO INVEST IN
RESEARCH IN FINLAND
We have a pleasure to invite you to the Symposium:
Brain Diseases - why to invest in research in Finland
on the 14th of October 2016 at 12:30–16:25.
The Symposium takes place at Haartman Institute, Lecture Hall 1,
University of Helsinki (Haartmaninkatu 3, 00290 Helsinki).
In Finland we have groundbreaking science in many fields of brain diseases.
Concurrent governmental actions such as the reform of the Biobank Act and
establishing the National Genomic Center will open up new avenues for cutting-edge
research and innovations for development of modern treatments for brain diseases.
This Symposium aims at creating an open mindset and identifying new ways to collaborate
between universities, hospitals, and industry. What is the key that our small country will
become the most attractive center for brain disease research in Europe?
Welcome!
Risto Renkonen
Dean,
Faculty of Medicine
University of Helsinki
Anne Remes
Professor
University of
Eastern Finland
Laura Airas
Adjunct Professor
University of Turku
Nina Forss
Head of Department
of Neurology
HUS
Marco Hautalahti
General Manager
Biogen Finland Oy
Pekka Simula
CEO
Herantis Pharma Plc.
Kiti Müller
Adjunct Professor
in Neurology
Nokia Technologies
Jussi Merikallio
General Manager
Pharma Industry
Finland
RSVP by October 7th at
alumniverkosto.helsinki.fi/Portal/Public/Event/Apply.aspx?EventID=659
Additional information:
[email protected], +358 2 941 24930
[email protected], +358 40 635 8411
PROGRAMME
11:30–12:30Lunch
12:30–12:40 Opening remarks
Dean Risto Renkonen, University of Helsinki
12:40–13:00 Burden of brain disorders in Finland. Opportunities for clinical
research and future therapeutic advances
Professor Reetta Kälviäinen, University of Eastern Finland and
the Finnish Neurological Society
13:00–13:20 Unmet medical need -driven innovations and R&D
collaboration in brain diseases in Europe
Ralph Kern, Senior Vice President, Worldwide Medical, Biogen
13:20–13:40 Decision supporting tool in brain diseases - case PredictND
Professor of Neurology Hilkka Soininen, University of Eastern Finland and
Dr Jyrki Lötjönen, Combinostics
13:40–14:00 Finnish government actions to boost health industry growth
Minister of Economic Affairs Olli Rehn, Ministry of Economic Affairs and
Employment
14:00–14:20 What makes Finland a unique country for patient care studies
in brain diseases?
Professor Aarno Palotie, FIMM, University of Helsinki and Broad Institute
of MIT and Harvard
14:20–14:30 CDNF: Finnish academia-industry collaboration for unique clinical
study in Parkinson's disease
CEO Pekka Simula, Herantis Pharma
14:30–15:00 Coffee break
15:00–15:20 Joining forces to improve MS care – case from Turku and Yale
Universities
Adjunct professor Laura Airas Yale University and University of Turku
15:20–15:40 Need for innovative solutions for outpatient care
Matti Vänskä, Director, Digital Health, Nokia Technologies
15:40–16:25 Summary session and discussion will be held in Finnish
Ministerial Adviser Saara Leppinen, Ministry of Social Affairs and Health
Head of Department of Neurology Nina Forss, HUS
General Manager Marco Hautalahti, Biogen Finland Oy,
Board Member of Pharma Industry Finland
16:25–16:40 Break with snacks
16:40–19:30 Satellite symposium “MS-taudin jatkuvasti muuttuva hoito”
Only for neurologists, in Finnish
Organized by Biogen Finland